Literature DB >> 16720682

Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.

Anna Krasnianski1, Walter J Schulz-Schaeffer, Kai Kallenberg, Bettina Meissner, Donald A Collie, Sigrun Roeber, Mario Bartl, Uta Heinemann, Daniela Varges, Hans A Kretzschmar, Inga Zerr.   

Abstract

Atypical clinical course and low sensitivity of established diagnostic tests are the main diagnostic problems in the MV2 subtype of sporadic Creutzfeldt-Jakob disease (sCJD). Clinical symptoms and signs, MRI, EEG and biochemical CSF markers were studied in 26 patients. Histological findings were semiquantitatively evaluated. Compared with typical sCJD, the disease duration was prolonged (median 12 months). Dementia, ataxia and psychiatric symptoms were present in all patients. Extrapyramidal signs were observed in 88%. T2-weighted MRI showed basal ganglia hyperintensities in 90%. Increased thalamic signal intensity was detected in 88% on diffusion-weighted MRI. Increased CSF tau-protein was found in 83%, and the 14-3-3 test was positive in 76%. The EEG revealed periodic sharp wave complexes in only two patients. Kuru plaques, severe thalamic and basal ganglia gliosis and spongiform changes, and neuronal loss in the pulvinar were the prominent histological features. At least one of the three diagnostic tests (MRI, tau- and 14-3-3 protein) supported the clinical diagnosis in all patients. MRI was the most sensitive of the diagnostic tests applied. Thalamic hyperintensities were observed unusually frequently. Prolonged disease duration, early and prominent psychiatric symptoms, absence of typical EEG, thalamic hyperintensities on MRI and relatively low 14-3-3 protein sensitivity may be suspicious for variant CJD. However, distinct sensory symptoms and young age at onset, which are often found in the latter, are not common in the MV2 subtype, and the pulvinar sign was observed in only one case.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720682     DOI: 10.1093/brain/awl123

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  25 in total

1.  Subacute progressive aphasia: a rare presentation of Creutzfeldt-Jakob disease.

Authors:  Javier Riancho; Manuel Delgado-Alvarado; José Luis Fernández-Torre; Pascual Sánchez-Juan; Jose Miguel Polo
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

2.  Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics.

Authors:  Ignazio Cali; Rudolph Castellani; Amer Alshekhlee; Yvonne Cohen; Janis Blevins; Jue Yuan; Jan P M Langeveld; Piero Parchi; Jiri G Safar; Wen-Quan Zou; Pierluigi Gambetti
Journal:  Brain       Date:  2009-09-04       Impact factor: 13.501

3.  First symptom and initial diagnosis in sporadic CJD patients in Germany.

Authors:  Anna Krasnianski; Judith Kaune; Klaus Jung; Hans A Kretzschmar; Inga Zerr
Journal:  J Neurol       Date:  2014-07-15       Impact factor: 4.849

4.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

5.  The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease.

Authors:  Cao Chen; Wei Zhou; Yan Lv; Qi Shi; Jing Wang; Kang Xiao; Li-Na Chen; Bao-Yun Zhang; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2015-07-19       Impact factor: 5.590

Review 6.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

7.  Atypical creutzfeldt-jakob disease evolution after electroconvulsive therapy for catatonic depression.

Authors:  Iria Grande; Juan Fortea; Ellen Gelpi; Itziar Flamarique; Marc Udina; Jordi Blanch; Raquel Sánchez-Valle
Journal:  Case Rep Psychiatry       Date:  2011-07-03

8.  A test for Creutzfeldt-Jakob disease using nasal brushings.

Authors:  Christina D Orrú; Matilde Bongianni; Giovanni Tonoli; Sergio Ferrari; Andrew G Hughson; Bradley R Groveman; Michele Fiorini; Maurizio Pocchiari; Salvatore Monaco; Byron Caughey; Gianluigi Zanusso
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

9.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

10.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.